What is the Prognosis for Patients with KRAS Mutations?
The presence of KRAS mutations is generally associated with a poorer prognosis compared to KRAS wild-type cancers. This is due to the aggressive nature of KRAS-mutated tumors and their resistance to conventional therapies. However, ongoing research and the development of new targeted therapies hold promise for improving outcomes in these patients.
